SCHEMBL5757335

SCHEMBL5757335

CSc1nc2ccc(S(=O)(=O)C(N[C@@H](C(=O)O)C(C)C)c3ccccc3)cc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.49
ALDH1A1 P00352 6/20 0.44
LMNA P02545 4/20 0.44
HTT P42858 4/20 0.44
HPGD P15428 2/20 0.44
HSP90AA1 P07900 1/20 0.44
TSHR P16473 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GLO1 Q04760 1/20 0.43
RAB9A P51151 5/20 0.42
NPC1 O15118 4/20 0.42
MAPT P10636 3/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CASP3 P42574 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754374 0.90 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2ARAB9A
SCHEMBL5758797 0.87 RAB9A (0.43) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL5758969 0.83 ALDH1A1 (0.44) ALDH1A1LMNAKMT2ARAB9AMAPT
SCHEMBL7216251 0.82 ALDH1A1 (0.43) ALDH1A1LMNAHPGDTSHRRAB9A
SCHEMBL5757339 0.81 PKM (0.56) PKMALDH1A1LMNAHTTHPGD
SCHEMBL5759548 0.75 ALDH1A1 (0.42) ALDH1A1LMNAHTTHPGDHSP90AA1
SCHEMBL5756601 0.74 PKM (0.55) PKMALDH1A1LMNAHTTHPGD
SCHEMBL5757303 0.73 MMP13 (0.55) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL5757327 0.73 MMP2 (0.56) PKMALDH1A1LMNANPSR1MEN1
SCHEMBL5755034 0.73 ALDH1A1 (0.55) PKMALDH1A1LMNAHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208092-B1 SULFONAMIDE DERIVATIVE AS A MATRIX METALLOPROTEINASE INHIBITOR SAMSUNG ELECTRONICS CO LTD (KR) 2006-06-21 EP disclosed
US-6548667-B2 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase SAMSUNG ELECTRONICS CO. LTD. (KR) 2003-04-15 US disclosed
US-20020169314-A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor SAMSUNG ELECTRONICS CO. LTD. (KR) 2002-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169314-A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor MMP9, MMP3, MMP14 PKM 2796/4885ALDH1A1 311/4885LMNA 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.